{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:57:48Z","timestamp":1772819868881,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11920-009-0054-5","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T07:23:47Z","timestamp":1254295427000},"page":"360-363","source":"Crossref","is-referenced-by-count":26,"title":["Treatment of opioid-dependent adolescents and young adults with buprenorphine"],"prefix":"10.1007","volume":"11","author":[{"given":"Geetha A.","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Woody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,1]]},"reference":[{"key":"54_CR1","doi-asserted-by":"crossref","unstructured":"Johnston LD, O\u2019Malley PM, Bachman JG, Schulenberg JE: Monitoring the Future: National Survey Results on Adolescent Drug Use: 1975\u20132006: Volume I, Secondary School Students. Bethesda, MD: National Institute on Drug Abuse; 2007 [NIH publication no. 07-6205.]","DOI":"10.1037\/e567272009-001"},{"key":"54_CR2","unstructured":"Substance Abuse and Mental Health Services Administration Office of Applied Studies: Drug Abuse Warning Network, 2006: National Estimates of Drug-related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies: Drug Abuse Warning Network, 2006; 2008 [DAWN Series D-30, DHHS publication no. (SMA) 08-4339.] http:\/\/dawninfo.samhsa.gov\/files\/ED2006\/DAWN2k6ED.pdf ."},{"key":"54_CR3","unstructured":"Substance Abuse and Mental Health Services Administration: Adapted by CESAR from Substance Abuse & Mental Health Data Archive (SAMHDA): Online analysis of the concatenated 1992-2004 TEDS data set, 2008. Available at http:\/\/www.icpsr.umich.edu\/SAMHDA\/ . Accessed November 15, 2006."},{"key":"54_CR4","unstructured":"Centers for Disease Control and Prevention: Viral hepatitis and injection drug users. Available at http:\/\/www.cdc.gov\/IDU\/hepatitis\/viral_hep_drug_use.htm . Accessed September 15, 2007."},{"key":"54_CR5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0306-4603(00)00115-5","volume":"26","author":"K.C. Ochoa","year":"2001","unstructured":"Ochoa KC, Hahn JA, Seal KH, Moss AR: Overdosing among young injection drug users in San Francisco. Addict Behav 2001, 26:453\u2013460.","journal-title":"Addict Behav"},{"key":"54_CR6","volume-title":"Treatment Episode Data Set (TEDS): 1995\u20132005. National Admissions to Substance Abuse Treatment Services","author":"Substance AbuseMental Health Services Administration Office of Applied Studies","year":"2007","unstructured":"Substance Abuse and Mental Health Services Administration Office of Applied Studies: Treatment Episode Data Set (TEDS): 1995\u20132005. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2007 [DASIS series: S-37, DHHS publication no. (SMA) 07-4234.]"},{"key":"54_CR7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/00004583-200010000-00021","volume":"39","author":"C.J. Hopfer","year":"2000","unstructured":"Hopfer CJ, Mikulich SK, Crowley TJ: Heroin use among adolescents in treatment for substance use disorders. J Am Acad Child Adolesc Psychiatry 2000, 39:1316\u20131323.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"54_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2004.10399726","volume":"36","author":"P. Clemmey","year":"2004","unstructured":"Clemmey P, Payne L, Fishman M: Clinical characteristics and treatment outcomes of adolescent heroin users. J Psychoactive Drugs 2004, 36:85\u201394.","journal-title":"J Psychoactive Drugs"},{"key":"54_CR9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1081\/ADA-200032300","volume":"30","author":"S.M. Gordon","year":"2004","unstructured":"Gordon SM, Mulvaney F, Rowan A: Characteristics of adolescents in residential treatment for heroin dependence. Am J Drug Alcohol Abuse 2004, 30:593\u2013603.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"54_CR10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","volume":"62","author":"L.A. Marsch","year":"2005","unstructured":"Marsch LA, Bickel WK, Badger GJ, et al.: Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry 2005, 62:1157\u20131164.","journal-title":"Arch Gen Psychiatry"},{"key":"54_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2008.07.016","volume":"99","author":"G.A. Subramaniam","year":"2009","unstructured":"Subramaniam GA, Stitzer MA, Woody GE, et al.: Clinical characteristics of treatment seeking adolescents with opioid versus cannabis\/alcohol use disorders. Drug Alcohol Depend 2009, 99:141\u2013149.","journal-title":"Drug Alcohol Depend"},{"key":"54_CR12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","volume":"300","author":"G. Woody","year":"2008","unstructured":"Woody G, Poole S, Subramaniam GA, et al.: Extended medication-assisted therapy produces better outcomes than detoxification among opioid-addicted youth. JAMA 2008, 300:2003\u20132011.","journal-title":"JAMA"},{"key":"54_CR13","volume-title":"Treatment episode data set, 1992\u20132006 (concatenated)","author":"Substance AbuseMental Health Services Administration Office of Applied Studies","year":"2008","unstructured":"Substance Abuse and Mental Health Services Administration Office of Applied Studies: Treatment episode data set, 1992\u20132006 (concatenated). Rockville, MD: Substance Abuse and Mental Health Services Administration Office of Applied Studies; 2008. Available at http:\/\/www.icpsr.umich.edu\/cgi-bin\/SDA\/SAMHDA\/hsda?samhda+tedsconcat . Accessed May 19, 2008."},{"key":"54_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0740-5472(02)00250-7","volume":"23","author":"C.J. Hopfer","year":"2002","unstructured":"Hopfer CJ, Khuri E, Crowley TJ, Hooks S: Adolescent heroin use: a review of the descriptive and treatment literature. J Subst Abuse Treat 2002, 23:231\u2013237.","journal-title":"J Subst Abuse Treat"},{"key":"54_CR15","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003: CD002209.","DOI":"10.1002\/14651858.CD002209"},{"key":"54_CR16","doi-asserted-by":"crossref","unstructured":"Mattick RP, Kimber J, Breen C, Davoli M: Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2008: CD002207.","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"54_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","volume":"28","author":"L. Amato","year":"2005","unstructured":"Amato L, Davoli M, Perucci CA, et al.: An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005, 28:321\u2013329.","journal-title":"J Subst Abuse Treat"},{"key":"54_CR18","volume-title":"State Methadone Treatment Guidelines, Treatment Improvement Protocol (TIP) Series 1","author":"M. Parrino","year":"1993","unstructured":"Parrino M: State Methadone Treatment Guidelines, Treatment Improvement Protocol (TIP) Series 1. Rockville, MD: Substance Abuse and Mental Health Services Administration; 1993 [DHHS publication no. (SMA) 93-1991.]"},{"key":"54_CR19","unstructured":"Substance Abuse and Mental Health Services Administration: Buprenorphine: the Drug Addiction Treatment Act of 2000 (DATA 2000). Available at http:\/\/buprenorphine.samhsa.gov\/index.html . Accessed May 5, 2009."},{"key":"54_CR20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","volume":"349","author":"P.J. Fudala","year":"2003","unstructured":"Fudala PJ, Bridge TP, Herbert S, et al.: Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003, 349:949\u2013958.","journal-title":"N Engl J Med"},{"key":"54_CR21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","volume":"55","author":"S.L. Walsh","year":"1994","unstructured":"Walsh SL, Preston KL, Stitzer ML, et al.: Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 1994, 55:569\u2013580.","journal-title":"Clin Pharmacol Ther"},{"key":"54_CR22","unstructured":"US Food and Drug Administration: NDA 20-732. NDA 20-733. Available at http:\/\/www.fda.gov\/cder\/foi\/label\/2002\/20732lbl.pdf . Accessed May 5, 2009."},{"key":"54_CR23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","volume":"88","author":"H. Alho","year":"2007","unstructured":"Alho H, Sinclair D, Vuori E, Holopainen A: Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend 2007, 88:75\u201378.","journal-title":"Drug Alcohol Depend"},{"key":"54_CR24","unstructured":"New York Academy of Medicine: Physician Clinical Support System (PCSS)\u2014buprenorphine: an educational resource for those treating patients with opioid dependence. 2005. Available at http:\/\/www.pcssbuprenorphine.org\/ . Accessed May 6, 2009."},{"key":"54_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"62","author":"S.D. Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, et al.: Injectable, sustainedrelease naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2006, 62:210\u2013218.","journal-title":"Arch Gen Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-009-0054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-009-0054-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-009-0054-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T23:41:51Z","timestamp":1685144511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-009-0054-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s11920-009-0054-5","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}